A remarkable characteristic of OIPCs is their ability to transition between the solid crystalline phase and the liquid phase, ...

KaliVir Immunotherapeutics has dosed the first subject in a Phase I/Ib clinical trial for its new oncolytic immunotherapy, ...

The surge in the adoption of renewable energy, coupled with the rapid growth of the electric vehicle market in recent years ...

Kineta has completed enrollment in the monotherapy cohorts of the Phase 1 VISTA-101 clinical trial.The ongoing Phase 1 study is now enrolling ...

Addressing stakeholders at the event, the Permanent Secretary, Ministry of Solid Minerals Development (MSMD), Dr Mary Ogbe, ...

Global disinflation remains on track. A soft landing appears to be the most likely scenario for the U.S. economy. What does ...

Primary target patient population for the CBX-12 Phase 2 study is women with platinum-resistant or refractory ovarian cancer who are naïve to ...

Black Diamond Therapeutics has deprioritized one of its two clinical-stage lung cancer contenders, jettisoned two executives ...

To enhance patient outcomes and increased trial success, Convert Pharma is leveraging companion AI- and genetic biomarkers, a ...

Recursion said it was able to use its AI-enabled drug discovery platform to identify a novel target and move all the way to ...

Oncoinvent, a clinical stage, radiopharmaceutical company developing innovative treatments for solid cancers, today announced ...

Organic ionic solid electrolytes (OIPCs) offer various desirable properties, with high potential as solid electrolytes for all-solid-state rechargeable batteries. However, they still need improvement ...